Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer

BACKGROUND: We aimed to understand the dependence of MEK and m-TOR inhibition in EGFR(WT)/ALK(non-rearranged) NSCLC cell lines. METHODS: In a panel of KRAS(M) and KRAS(WT) NSCLC cell lines, we determined growth inhibition (GI) following maximal reduction in p-ERK and p-S6RP caused by trametinib (MEK...

Descripción completa

Detalles Bibliográficos
Autores principales: Broutin, Sophie, Stewart, Adam, Thavasu, Parames, Paci, Angelo, Bidart, Jean-Michel, Banerji, Udai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997545/
https://www.ncbi.nlm.nih.gov/pubmed/27441499
http://dx.doi.org/10.1038/bjc.2016.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997545/
https://www.ncbi.nlm.nih.gov/pubmed/27441499
http://dx.doi.org/10.1038/bjc.2016.220

Ejemplares similares